Clinical trial
Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2…
NCT00324675 · Technische Universität Dresden, Other · Completed
Key facts
| NCT number | NCT00324675 |
|---|---|
| Title | Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy |
| Official title | Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy |
| Lead sponsor | Technische Universität Dresden, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type 2 Diabetes, Overt Diabetic Nephropathy |
| Intervention type | Drug |
| Interventions | Rosiglitazone, Placebo |
| Enrollment | 28 |
| Start date | Aug 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2010 |
| First posted | May 11, 2006 |
| Last update posted | Nov 2, 2011 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: